A detailed history of Meritage Portfolio Management transactions in Novartis Ag stock. As of the latest transaction made, Meritage Portfolio Management holds 45,638 shares of NVS stock, worth $4.76 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
45,638
Previous 46,255 1.33%
Holding current value
$4.76 Million
Previous $4.92 Million 6.6%
% of portfolio
0.32%
Previous 0.31%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$106.13 - $120.89 $65,482 - $74,589
-617 Reduced 1.33%
45,638 $5.25 Million
Q2 2024

Aug 08, 2024

BUY
$92.57 - $107.37 $4.28 Million - $4.97 Million
46,255 New
46,255 $4.92 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Meritage Portfolio Management Portfolio

Follow Meritage Portfolio Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.